Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Leishmaniasis is one of the major neglected tropical diseases of the world. Druggable targets are the parasites’ cysteine proteases (CPs) of clan CA, family C1 (CAC1). In previous studies we identified two peptidomimetic compounds, the aziridine-2,3-dicarboxylates 13b and 13e, out of a series of inh...

Full description

Bibliographic Details

Published:	2016
Subjects:	Aziridine cathepsins Leishmania cysteine protease inhibitor selectivity
Online Access:	http://hdl.handle.net/10872/13968
Tags:	Add Tag No Tags, Be the first to tag this record!